Champions Oncology, Inc.

Champions Oncology, Inc.

4.30
EUR
0.00
(0.00%)
-0.07EPS
65.42MMarket Cap
Dec 15Next Earn

Latest Stock Split

Aug 12, 2015

1:12

For every 12 shares held, investors received 1.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Aug 12, 2015
    Before—
    Split ratio1:12
    After—
    Reverse
  2. Nov 01, 1991
    Before—
    Split ratio1:100
    After—
    Reverse

About Champions Oncology, Inc. stock splits

Champions Oncology, Inc. (GETTEX:2I3) operates in the Biotechnology industry.

Champions Oncology, Inc. company overview

When did Champions Oncology, Inc. stock split?

Champions Oncology, Inc.'s most recent stock split was on August 12, 2015. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.

What is Champions Oncology, Inc.'s stock split history?

Champions Oncology, Inc. (GETTEX:2I3) has split its stock 2 times: a 1-for-100 reverse split on November 1, 1991 and a 1-for-12 reverse split on August 12, 2015.

How many times has Champions Oncology, Inc. stock split?

Champions Oncology, Inc. has split its stock 2 times. This history records 2 reverse splits between November 1, 1991 and August 12, 2015.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Champions Oncology, Inc.'s 1-for-12 reverse split on August 12, 2015, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Champions Oncology, Inc. split its stock again?

Champions Oncology, Inc. has not announced a new split in our records. Its most recent split was on August 12, 2015, 11 years ago. Companies announce splits in advance, and any new GETTEX:2I3 split will appear on this page.